Gladstone Institutional Advisory’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Gladstone Institutional Advisory’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$460K	Buy	+8,102	New	+$386K	0.01%	613

Other funds holding GNOM

SLT Holdings Scottsdale, Arizona $160M AUM 52.3% 1-Year Est. Return

Wealth Management Partners Tucson, Arizona $425M AUM 60.71% 1-Year Est. Return

Sightline Wealth Advisors Groton, Connecticut $273M AUM 18.08% 1-Year Est. Return

Armis Advisers Atlanta, Georgia $1.09B AUM 22.88% 1-Year Est. Return

J.W. Cole Advisors Tampa, Florida $5.83B AUM 32.38% 1-Year Est. Return

Halbert Hargrove Global Advisors Long Beach, California $2.31B AUM 21.64% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Triumph Capital Management Denver, Colorado $552M AUM 20.75% 1-Year Est. Return

Capital Investment Advisory Services Raleigh, North Carolina $1.62B AUM 27.01% 1-Year Est. Return

Gladstone Institutional Advisory's GNOM Position: Q2 2026 in Review

Gladstone Institutional Advisory opened a new position in Global X Genomics & Biotechnology ETF (GNOM) in Q2 2026: 8,102 shares worth $460K. The stake represents 0.01% of the portfolio and ranks #613 among its holdings.

13 funds tracked by Wall St. Rank hold GNOM as of Q2 2026.

Gladstone Institutional Advisory held 8,102 shares of Global X Genomics & Biotechnology ETF worth $460K as of Q2 2026.
Global X Genomics & Biotechnology ETF was a new Gladstone Institutional Advisory position in Q2 2026.
Global X Genomics & Biotechnology ETF made up 0.01% of Gladstone Institutional Advisory's portfolio in Q2 2026, its #613 holding.
13 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2026.

Based on Gladstone Institutional Advisory's 13F filing for Q2 2026, filed 27 Jul 2026.